Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells.
about
Roles for miRNAs in endocrine resistance in breast cancermiRNA biogenesis: biological impact in the development of cancerRegulation of microRNA biogenesis and turnover by animals and their virusesVitamin D and microRNAs in boneExploring circulating micro-RNA in the neoadjuvant treatment of breast cancerP21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancerA daphnane diterpenoid isolated from Wikstroemia polyantha induces an inflammatory response and modulates miRNA activityMiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinomaMicromanaging vascular biology: tiny microRNAs play big bandIdentification of small molecules that suppress microRNA function and reverse tumorigenesis.Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes.The protein kinase TOUSLED facilitates RNAi in Arabidopsis.The roles of individual mammalian argonautes in RNA interference in vivo.Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation.High-throughput experimental studies to identify miRNA targets directly, with special focus on the mammalian brain.Cell stress is related to re-localization of Argonaute 2 and to decreased RNA interference in human cellsCommon genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival.Mechanisms of control of microRNA biogenesis.Genome wide screening of RNAi factors of Sf21 cells reveal several novel pathway associated proteinsMicroarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor.MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory PathwaysReduction of microRNA-206 contributes to the development of bronchopulmonary dysplasia through up-regulation of fibronectin 1.p47phox and reactive oxygen species production modulate expression of microRNA-451 in macrophagesRegulation of MicroRNA Biogenesis: A miRiad of mechanismsIdentification of therapeutic targets for breast cancer using biological informatics methods.miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.miRNAs and estrogen action.Regulation of senescence by microRNA biogenesis factorsKalirin-9 and Kalirin-12 Play Essential Roles in Dendritic Outgrowth and Branching.Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancerRegulation of HBEGF by Micro-RNA for Survival of Developing Human Trophoblast Cells.Sex differences in microRNA regulation of gene expression: no smoke, just miRsStudy on the clinical significance of Argonaute2 expression in colonic carcinoma by tissue microarrayT cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire.microRNA Regulation and Its Consequences in CancerArgonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.Studying microRNAs in the brain: technical lessons learned from the first ten years.Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review).Estrogen Regulation of MicroRNA Expression
P2860
Q26783076-449C97E1-C1E9-4621-B4B4-C7050E8FD23EQ26824263-6849A230-E89D-42B3-88B9-31F50931A234Q27014955-629775D5-7592-4B5F-AD28-5EEF94B2A838Q27015808-56D353FD-5F99-44DB-B9B4-148773C0AB85Q28066481-275DE5EA-1512-4E66-A6BA-C37D3DD16AE5Q28294949-E94456A2-47CD-4649-98E5-986C95977BDCQ28727976-ECF6F9D1-C43C-4BCE-ABFF-7D1400F34A62Q33555052-BDB522BA-E72D-4C3A-B2AC-17DDEDCCB9E1Q33578296-2E723F42-F0A4-4F1D-9CB6-BD72CBE2C7D4Q33597265-A49179CB-C7EC-45C6-B77E-C817FBA9E99DQ33611616-CF0AE937-76A3-4DDA-B18A-58FA40AC513FQ33843059-1545374B-4797-41B3-8B4B-8B72AD697F11Q33846059-4DA84F11-74A3-4AB5-92E9-FAF9E74CBA83Q33939162-C90C3A61-5526-48B2-97A8-9FB5AB3FECC8Q33943476-EECB49D1-DAEF-4E5B-8AF5-216D3735A14AQ34154255-692571C7-6EC4-40B5-80FE-C5DF3135D375Q34284145-61806775-B6DC-4258-B650-F68CAA9ED8C5Q34310633-C018480F-4E52-4E65-ADB0-500CCAD67817Q34584462-8E3DC2FF-2424-4D10-9BB5-092FFF0C503CQ34750470-83B4BE77-C2BE-4D39-BF9F-B30F6EB1E930Q34868281-E52F4C21-09A1-4ED7-B71E-3FC98C065A50Q34990323-A8412819-AB3C-495E-8401-19D0DECA94BCQ35180319-A3C4966E-D68E-4B92-AAE8-717A2FD638F3Q35575239-FA947169-28D3-4CA5-B2D6-C149129310ECQ35726382-0F315B37-8C53-4C1A-BCAC-2CF6AB3133DEQ35912303-F6667155-04EC-4605-AD58-9EDA0B5C166EQ35946984-BC9E70A8-3E08-4DF1-888E-5D914638BA28Q35948994-F2EAA950-35EC-456F-8ED0-DADED8068B1EQ36098736-90F6F88E-3B15-4716-A2D3-BFC4E0717AB3Q36140898-2D951BA8-7B21-4DFA-BF40-6E302149FA52Q36152760-1E9C4B3A-B558-4C32-9C6B-8608D11BFABFQ36427075-9AFBC197-89D8-457C-BBEE-C45025EF92ADQ36584345-F9A5394D-1602-4CE1-9A96-DDF07BF1BF71Q36603499-ABCD6FEA-D405-4622-B423-EF2931CA970DQ36607817-8D78B6B6-5801-4DAF-AA00-7063C2DA3B5AQ36746133-9214E331-B84F-4857-B76F-760A910BF1C3Q36792134-9BE3810B-BB66-4720-A48A-B67C165F4D11Q36798899-19C60435-7444-4B5A-9085-9E104FE7B856Q37211627-3B3D2F64-95CE-43AF-BE8B-F66A303E6988Q37250659-808DE784-948F-450F-AEF9-2010BDED5B60
P2860
Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Argonaute-2 expression is regu ...... notype in breast cancer cells.
@en
Argonaute-2 expression is regu ...... notype in breast cancer cells.
@nl
type
label
Argonaute-2 expression is regu ...... notype in breast cancer cells.
@en
Argonaute-2 expression is regu ...... notype in breast cancer cells.
@nl
prefLabel
Argonaute-2 expression is regu ...... notype in breast cancer cells.
@en
Argonaute-2 expression is regu ...... notype in breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Argonaute-2 expression is regu ...... notype in breast cancer cells.
@en
P2093
Brian D Adams
Bruce A White
Kevin P Claffey
P2860
P356
10.1210/EN.2008-0984
P407
P577
2008-09-11T00:00:00Z